Anthem Blue Cross Blue Shield of California policy
LAB.00046 Testing for Biochemical Markers for Alzheimer’s Disease
LAB.00046 Testing for Biochemical Markers for Alzheimer’s Disease is a public Anthem Blue Cross Blue Shield of California policy (policy LAB.00046). It lists 19 CPT or HCPCS codes, 14 of them on the Anthem Blue Cross Blue Shield of California prior authorization list. Not a coverage decision; the payer's own document governs.
Check eligibility for free
No account required. Sign a BAA to see plan details, coordination of benefits and more
- Policy number
- LAB.00046
- Line of business
- Commercial
- Source
- www.anthem.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross Blue Shield of California prior authorization list.
| Code | Prior authorization | Description on the prior authorization list | Other Anthem Blue Cross Blue Shield of California policies |
|---|---|---|---|
| 0206U | Not listed | Policies naming 0206U | |
| 0207U | On the list | Neurology (Alzheimer disease); quantitative imaging of phosphorylated ERK1 and ERK2 in response to bradykinin treatment by in situ immunofluorescence, using cultured skin fibroblasts, reported as a probability index for Alzheimer disease | Policies naming 0207U |
| 0358U | On the list | Neurology (mild cognitive impairment), analysis of β-amyloid 1- 42 and 1-40, chemiluminescence enzyme immunoassay, cerebral spinal fluid, reported as positive, likely positive, or negative | Policies naming 0358U |
| 0412U | On the list | Beta amyloid, Aβ42/40 ratio, immunoprecipitation with quantitation by liquid chromatography with tandem mass spectrometry (LC-MS/MS) and qualitative ApoE isoformspecific proteotyping, plasma combined with age, algorithm reported as presence or absence of brain amyloid pathology | Policies naming 0412U |
| 0445U | Not listed | Policies naming 0445U | |
| 0459U | On the list | β-amyloid (Abeta42) and total tau (tTau), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology (Elecsys® Total Tau CSF [tTau] and β-Amyloid [1- 42] CSF II [Abeta 42] Ratio) | Policies naming 0459U |
| 0479U | Not listed | Policies naming 0479U | |
| 0503U | On the list | Neurology (Alzheimer disease), beta amyloid (AB40, AB42, AB42/40 ratio) and tau-protein (ptau217, np-tau217, ptau217/np-tau217 ratio), blood, immunoprecipitation with quantitation by liquid chromatography with tandem mass spectrometry (LC-MS/MS), algorithm score reported as likelihood of positive or negative for amyloid plaques | Policies naming 0503U |
| 0547U | Not listed | Policies naming 0547U | |
| 0568U | Not listed | Policies naming 0568U | |
| 0596U | On the list | Neurology (Alzheimer disease), plasma, 3 distinct isoform- specific peptides (APOE2, APOE3, and APOE4) by liquid chromatography with tandem mass spectrometry (LC- MS/MS), reported as an APOE proteotype | Policies naming 0596U |
| 81599 | On the list | Unlisted multianalyte assay with algorithmic analysis | Policies naming 81599 |
| 82233 | On the list | Beta-amyloid; 1-40 (Abeta 40) | Policies naming 82233 |
| 82234 | On the list | Beta-amyloid; 1-42 (Abeta 42) | Policies naming 82234 |
| 83520 | On the list | Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; quantitative, not otherwise specified or [when specified as testing for food allergy or sensitivity (e.g., IgG testing)] or [when specified as tau protein, amyloid beta peptide testing] | Policies naming 83520 |
| 83884 | On the list | Neurofilament light chain (NfL) | Policies naming 83884 |
| 84393 | On the list | Tau, phosphorylated (e.g., pTau 181, pTau 217), each | Policies naming 84393 |
| 84394 | On the list | Tau, total (tTau) | Policies naming 84394 |
| 84999 | On the list | Unlisted chemistry procedure | Policies naming 84999 |
All Anthem Blue Cross Blue Shield of California policies · Anthem Blue Cross Blue Shield of California prior authorization CPT list